MSB 13.3% $1.53 mesoblast limited

Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-70

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 254 Posts.
    lightbulb Created with Sketch. 102
    Note it down guys.

    100% Risk OFF until 2ng August 2023.

    Among steady rise till then, next bounces imminent on news of
    - CHF meeting with FDA
    - CLBP trial kick-off
    - progress toewards ARDS trial

    Take it the way you can.
    Not an advice


    Last edited by bontz777: 08/03/23
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.